| Product Code: ETC11635567 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Israel continued to rely on a diverse range of countries for its cholesterol-lowering agents imports, with top exporters being Switzerland, UK, Belgium, USA, and Germany. The market showed low concentration levels with a Herfindahl-Hirschman Index (HHI) remaining very low. The compound annual growth rate (CAGR) from 2020 to 2024 was -2.14%, indicating a declining trend, while the growth rate from 2023 to 2024 further decreased to -0.41%. This data suggests a challenging landscape for cholesterol-lowering agents import market in Israel, with potential implications for industry stakeholders to strategize for future growth.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Cholesterol Lowering Agents Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Cholesterol Lowering Agents Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Cholesterol Lowering Agents Market - Industry Life Cycle |
3.4 Israel Cholesterol Lowering Agents Market - Porter's Five Forces |
3.5 Israel Cholesterol Lowering Agents Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Israel Cholesterol Lowering Agents Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 Israel Cholesterol Lowering Agents Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Cholesterol Lowering Agents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of managing cholesterol levels for overall health |
4.2.2 Growing prevalence of lifestyle diseases such as obesity and diabetes leading to higher demand for cholesterol lowering agents |
4.2.3 Technological advancements in drug development leading to more effective and safer cholesterol lowering medications |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for new cholesterol lowering agents in Israel |
4.3.2 Competition from alternative therapies such as dietary supplements and lifestyle modifications impacting market growth |
4.3.3 Adverse side effects associated with some cholesterol lowering medications affecting patient compliance |
5 Israel Cholesterol Lowering Agents Market Trends |
6 Israel Cholesterol Lowering Agents Market, By Types |
6.1 Israel Cholesterol Lowering Agents Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Israel Cholesterol Lowering Agents Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 Israel Cholesterol Lowering Agents Market Revenues & Volume, By Statins, 2021 - 2031F |
6.1.4 Israel Cholesterol Lowering Agents Market Revenues & Volume, By Bile Acid Sequestrants, 2021 - 2031F |
6.1.5 Israel Cholesterol Lowering Agents Market Revenues & Volume, By Nicotinic Acid, 2021 - 2031F |
6.1.6 Israel Cholesterol Lowering Agents Market Revenues & Volume, By PCSK9 Inhibitors, 2021 - 2031F |
6.1.7 Israel Cholesterol Lowering Agents Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Israel Cholesterol Lowering Agents Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Cholesterol Lowering Agents Market Revenues & Volume, By Hypercholesterolemia, 2021 - 2031F |
6.2.3 Israel Cholesterol Lowering Agents Market Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031F |
6.2.4 Israel Cholesterol Lowering Agents Market Revenues & Volume, By Hyperlipidemia, 2021 - 2031F |
6.3 Israel Cholesterol Lowering Agents Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Israel Cholesterol Lowering Agents Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.3.3 Israel Cholesterol Lowering Agents Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.3.4 Israel Cholesterol Lowering Agents Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
7 Israel Cholesterol Lowering Agents Market Import-Export Trade Statistics |
7.1 Israel Cholesterol Lowering Agents Market Export to Major Countries |
7.2 Israel Cholesterol Lowering Agents Market Imports from Major Countries |
8 Israel Cholesterol Lowering Agents Market Key Performance Indicators |
8.1 Average cost of cholesterol lowering agents in Israel |
8.2 Number of prescriptions for cholesterol lowering medications |
8.3 Patient adherence rates to prescribed cholesterol lowering therapies |
8.4 Rate of new product developments and approvals in the cholesterol lowering agents market in Israel |
8.5 Number of patients diagnosed with high cholesterol levels opting for pharmacological treatment |
9 Israel Cholesterol Lowering Agents Market - Opportunity Assessment |
9.1 Israel Cholesterol Lowering Agents Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Israel Cholesterol Lowering Agents Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.3 Israel Cholesterol Lowering Agents Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Cholesterol Lowering Agents Market - Competitive Landscape |
10.1 Israel Cholesterol Lowering Agents Market Revenue Share, By Companies, 2024 |
10.2 Israel Cholesterol Lowering Agents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here